Home
Biosion

Biosion Market Share Analysis for May 2026

Industry: N/A

Domainbiosion.com

Year Founded2017

Employees51 - 200

Annual Revenue$5M - $10M

Biosion

Biosion (including company regionals)

biosion.com

See more website traffic and engagement information

Biosion Revenue up to May 2026 is 5M - 10M

revenue generated by Biosion top domains

Biosion top domains revenue over 3 years

Revenue for Biosion top domains

biosion.com5M - 10M

See more with Sales Intelligence

Total visits to Biosion's top domains

Understand Biosion market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

biosion.com233

See more with Sales Intelligence

Avg. visit duration in Biosion's top domains

Analyze Biosion engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

biosion.com--

See more with Sales Intelligence

Avg. pageviews on Biosion's top domains

See how Biosion keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

biosion.com1.09

See more with Sales Intelligence

Biosion top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Biosion

These are the website technologies, by industry, used by Biosion top domains

Widget (3)

Twemoji

Email Services (2)

GoDaddy Email

Mobile (2)

Meta Viewport

Social (2)

AddToAny

More Technologies

8

See all

News & Signals from Biosion

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBiosion, Inc. hired Kedan Lin as Chief Development Officer and President of Biosion US on Feb 19th '25.NEWARK, Del. and NANJING, China, Feb. 19, 2025 /PRNewswire/ - Biosion, Inc. ("Biosion"), a global clinical-stage biotechnology company, is pleased to announce the appointment of Kedan Lin, Ph.D., as Chief Development Officer and President of Biosion US.

NewsBiosion, Inc. receives financing of $40M.Under the terms of the agreement, Biosion will receive more than $40m in upfront payment, license fee and compensation for certain development costs and drug product materials.

NewsAclaris Therapeutics, Inc. partnered with Biosion, Inc. on Nov 19th '24.On Tuesday, Aclaris Therapeutics (NASDAQ: NASDAQ:ACRS) announced a significant licensing agreement with Biosion, acquiring global rights, excluding China, to two potential treatments for inflammatory conditions.